PROLONGED HEMODIALYSIS ON THE GENIUS® HYBRID SYSTEM USING THREE ANTICOAGULATION METHODS: EVALUATION OF ADVERSE OUTCOMES.

https://storage.unitedwebnetwork.com/files/1099/7141a7f912cc0a40e98e8df20ae057d5.pdf
PROLONGED HEMODIALYSIS ON THE GENIUS® HYBRID SYSTEM USING THREE ANTICOAGULATION METHODS: EVALUATION OF ADVERSE OUTCOMES.
Carlos Eduardo
Poli de Figueiredo
Amanda Corrêa-dos-Santos amanda.santos94@edu.pucrs.br Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Isabel Cristina Reinheimer isabel.reinheimer@edu.pucrs.br Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Amanda da Silva Salim amanda.salim@edu.pucrs.br Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Health and Life Sciences - Nephrology Laboratory Porto Alegre
Gabriela Boff Comiran g.boff@edu.pucrs.br Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Adriana Mattedi Soares adriana.mattedi@edu.pucrs.br Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Lorenzo de Lemos Bernd lorenzolbernd@gmail.com Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Luiza Aguirre Susin luiza-aguirre@hotmail.com Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Luis Fernando Salazar Hortua luis.salazar.hortua@gmail.com Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Ana Paula Machado Wolffenbüttel ana.w@edu.pucrs.br Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Dante Ferreira Felloni Borges dantefelloni@gmail.com Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Jorge Alberto Menegasso Vieira jorgealbertomv@gmail.com University of Caxias do Sul (UCS) Nephrology Caxias do Sul
Elisabete Oliveira-de-Castro elisabeteoliveiradecastro@gmail.com Hospital São Lucas-PUCRS Dialysis Unit Porto Alegre
Luciano da Silva Selistre selistre71@gmail.com University of Caxias do Sul (UCS) Nephrology Caxias do Sul
Daniele Cristóvão Escouto daniele.escouto@pucrs.br Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre
Carlos Eduardo Poli-de-Figueiredo cepolif@pucrs.br Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine - Nephrology Laboratory Porto Alegre

Prolonged hemodialysis (HD) has stood out for its ease of application and shorter duration of therapy than continuous HD (> 6 to 12 hours). The use of the Genius® hybrid system offers advantages such as bacteriological safety, and a portable, hermetically sealed tank with thermal insulation. However, prolonged HD is not exempt from complications. Therefore, this study aims to analyze the adverse outcomes of patients undergoing prolonged HD with the Genius® hybrid system, with special attention given to the anticoagulation method.


A retrospective cohort study at a University Hospital Nephrology Unit. Exposure: Patients on prolonged HD (> 6 hours) in a Genius® hybrid system. Anticoagulation was with three methods: washing the extracorporeal system with 0.9% saline, regional anticoagulation with 4% sodium citrate, or systemic anticoagulation with unfractionated heparin. The following adverse outcomes have been registered: thrombosis, intradialytic hypotension, hypertension, fluid and electrolyte disorders, dysnatremia, acidosis, alkalosis, citrate intoxication, bleeding, death, and days in the Intensive Care Unit (ICU). Inclusion criteria were patients > 18 years old with acute kidney injury (AKI) or chronic kidney disease (CKD) who underwent exposure from 03-09/2023. Data have been collected from electronic medical records and managed on the REDCap® platform. Statistical analysis used IBM SPSS Statistics version 29.0.1.0 software (171). The University Ethics Committee approved the study (Report No. 5,816,491).

A total of 54 patients were included and 296 prolonged Genius® hybrid system HD sessions were evaluated. Most were men n=33 (61.1%), average age of 73.3 years (±13.4), and had hypertension n=40 (74%), diabetes n=21 (38.9%), and obesity n=16 (29.6%). Most sessions (59.1%) used saline lavage as an anticoagulation method, followed by unfractionated heparin (33.4%) and sodium citrate (7.2%). The patient sample presented an elderly, male, a hypertensive profile, with multi-comorbidities and a diagnosis of AKI. Other clinical characteristics are presented in Table 1. Concerning the adverse outcomes of dialysis sessions, intradialytic hypotension (IDH) was the most frequent ( 40.9%), followed by System Coagulation (28.7%). Other outcomes were described in Table 2. There was no bleeding, hyponatremia, citrate poisoning or alkalosis. The occurrence of death was 66.7% and the average stay in the ICU was 14.7 days.

The study demonstrates high mortality in the sample and an average stay in the ICU of two weeks. These values may be related to the profile of the patients: multi-comorbid elderly individuals admitted to the ICU. Intradialytic hypotension and system thrombosis were the most frequent complications. The most used anticoagulation method was line and filter washing with 0.9% saline, which may have had an impact on the reported rate of thrombosis. This fact is due to the lack of reimbursement for the use of citrate anticoagulation by the public health system.

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos